As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...

Over 40% of nearly 8,600 US adults who had advanced hepatitis B–related liver disease appear to have received no treatment ...

The search for new treatments for hepatitis B has been ongoing for decades. While effective at suppressing the virus, current treatments, which include antivirals, cannot eliminate it from the liver.

Hepatitis B virus (HBV) causes hepatitis B. Worldwide, hepatitis B is thought to be the second deadliest infection; it's estimated that about five percent of the global population have the disease.

The three-dose hepatitis B vaccine has a long track record of safety, but rolling back recommendations could leave kids ...

A landmark inquiry investigating the worst treatment disaster in the history of the NHS is set to conclude on Monday. Between the 1970s and early 1990s, patients were given contaminated blood and ...

New medications called direct-acting antivirals (DAAs) have transformed the treatment of hepatitis C. Twelve weeks on one of these drugs cures the infection in 95 percent or more of people who take it ...

The hepatitis C virus—HCV—can persist in the livers of those infected and even lead to liver disease or failure in extreme ...

Glecaprevir/pibrentasvir cleared infection in nearly all patients in a global phase IIIb s ...